Bringing the very best science and medicine to our best equine friends
News

Kindred Biosciences Receives Approval of Effectiveness Technical Section from FDA for Zimeta New Animal Drug Application

San Francisco, CA (October 4, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced it has received a technical section complete letter for effectiveness from the U.S. Food and Drug Administration’s Center for Veterinary Medicine for Zimeta™ (dipyrone injection) approving the technical section. The basis for this complete letter was a multicenter, randomized, blinded, placebo-controlled pivotal study that enrolled 138 horses to assess the effectiveness of Zimeta. The primary endpoint was improvement (a 2°F or greater decrease in temperature from baseline) or resolution of fever (a return to normothermia …

Continue Reading

KindredBio supports New Horizon Ranch – both working to strengthen the bond between horses and humans

KindredBio is a veterinary biopharmaceutical company based in Burlingame, CA that is focused on a strong development pipeline serving the horse with the motto “best medicines for our best friends.” KindredBio’s co-founder and many employees are horse people and advocates for the bond between horses and people with an understanding of how these animals change people’s lives. The value of the horse goes way beyond high end athletes such as our Olympic horses or Kentucky Derby winners.  Even retired or back yard horses touch human lives in unimaginable ways.  New Horizon ranch is a therapeutic riding center located in Rantoul, ...
Continue Reading

QH Kids in STEM Sign-Up Opens

QH Kids in STEM Sign-Up Opens Sponsored by Kindred Biosciences to encourage youth from quarter horse backgrounds to study and pursue careers in science, technology, engineering and mathematics. Indianola, IA: The GoodRide Group STEM Alliance and Kindred Biosciences (NASDAQ: KIN) are excited to announce that youth and parents from around the country can sign up to participate at no cost in QH Kids in STEM. “Inspire and engage is the goal for QH Kids in STEM digital series as the demand for skilled workers in science, technology, engineering and mathematics continues to rise,” cited Kris Moorman, founder of The GoodRide …

Continue Reading

Kindred Biosciences Announces Initiation of Pilot Field Study of Atopic Dermatitis and Other Updates

San Francisco, CA (June 14, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced the initiation of a pilot field study designed to test several molecules, including anti-cytokine antibodies, in dogs with atopic dermatitis. The pilot field study in dogs with atopic dermatitis is a multi-center pilot study to assess safety and efficacy of several molecules, and to determine the candidate(s) that will be taken into further development. In addition, KindredBio provided an update on its equine biologics program. The first stage of a pilot field study in sick or …

Continue Reading

World’s Top Show Jumper, McLain Ward, wins the $15,000 KindredBio Jumper Prix

Saugerties, NY (June 12, 2016) The HITS-on-the-Hudson III at the Grand Prix Stadium saw some excellent competition on Saturday and we were excited to see the action around the $15,000 KindredBio 1.40M Jumper Prix. McLain Ward, a two-time Olympic gold medalist and currently ranked the #1 show jumper in the world, aboard Best Buy, a nine-year-old Holsteiner mare owned by Double H Farm, topped the competition. The team was clean in the first round along with 8 other horse and rider combinations.  Ward and Best Buy had a fast and clean jump-off round, navigating the tough track in a fast …

Continue Reading

Kindred Biosciences Announces HITS Sponsorship

San Francisco, CA (May 25, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, is pleased to announce their Platinum Sponsorship of the HITS Horse Show series.  The sponsorship will start this week at the Saugerties, New York facility for the HITS-on-the-Hudson series and will extend through both the HITS Ocala Winter Circuit in Ocala, Florida, and the HITS Desert Circuit in Thermal, California. Denise Bevers, Co-Founder and Chief Operating Officer, said, “As a company dedicated to developing innovative medications for our horse companions, we are very pleased to be partnering …

Continue Reading

Kindred Biosciences Announces First Quarter 2016 Financial Results

San Francisco, CA (May 5, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the first quarter ended March 31, 2016 and provided updates on its programs. “We successfully advanced our lead product candidates in the first quarter. We look forward to reporting topline results for KIND-010, a transdermal gel for the management of weight loss in cats, by mid-year, as planned. Additionally, preparations for the commercial launch of Zimeta for fever in horses are on track, positioning KindredBio for the expected revenue generation by the …

Continue Reading